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Abstract: Rift Valley fever (RVF) is a neglected, emerging,
mosquito-borne disease with severe negative impact on
human and animal health and economy. RVF is caused by
RVF virus (RVFV) affecting humans and a wide range of
animals. The virus is transmitted through bites from
mosquitoes and exposure to viremic blood, body fluids, or
tissues of infected animals. During 2007 a large RVF
outbreak occurred in Sudan with a total of 747 confirmed
human cases including 230 deaths (case fatality 30.8%);
although it has been estimated 75,000 were infected. It
was most severe in White Nile, El Gezira, and Sennar states
near to the White Nile and the Blue Nile Rivers. Notably,
RVF was not demonstrated in livestock until after the
human cases appeared and unfortunately, there are no
records or reports of the number of affected animals or
deaths. Ideally, animals should serve as sentinels to
prevent loss of human life, but the situation here was
reversed. Animal contact seemed to be the most
dominant risk factor followed by animal products and
mosquito bites. The Sudan outbreak followed an unusu-
ally heavy rainfall in the country with severe flooding and
previous studies on RVF in Sudan suggest that RVFV is
endemic in parts of Sudan. An RVF outbreak results in
human disease, but also large economic loss with an
impact beyond the immediate influence on the directly
affected agricultural producers. The outbreak emphasizes
the need for collaboration between veterinary and health
authorities, entomologists, environmental specialists, and
biologists, as the best strategy towards the prevention
and control of RVF.
Introduction
Globally, vector-borne diseases are responsible for almost 20%
of the infectious diseases affecting humanity, and developing
countries in Africa suffer most from the vector-borne disease
burden and its socioeconomic consequences [1,2]. Rift Valley
fever (RVF), is a neglected, emerging, mosquito-borne disease with
severe negative impact on human and animal health and
economy, exaggerating poverty to already deprived communities.
RVF is caused by RVF virus (RVFV) belonging to the Bunyaviridae
family, genus Phlebovirus affecting humans and a wide range of
animals [3,4]. The virus is transmitted through bites from
mosquitoes and exposure to blood, body fluids, or tissues of
infected animals [3,4]. RVFV was first isolated in Kenya 1930 [5],
and 6 years later RVFV antibodies were found in human sera
from southern Sudan [6]. Since then, RVF outbreaks have been
recorded in many countries in sub-Saharan Africa [7], and
recently it has emerged in new geographical areas with outbreaks
reported in Yemen and Saudi Arabia in 2000 [8]. During 2006/
2007 a large RVF outbreak occurred in the Horn of Africa. Sudan
was severely affected during the second half of 2007 [9]. This
article summarizes the knowledge gathered on RVFV activity in
Sudan focusing on the 2007 outbreak and emphasizes the essential
role of the policy maker in the prevention and control of RVF.
Methods
Using the terms ‘‘Sudan’’ and ‘‘Rift Valley fever’’ 26 articles
were identified by searching Medline through PubMed (http://
www.ncbi.nlm.nih.gov/sites/entrez/) and by using ‘‘Rift Valley
fever’’ alone, 1,010 articles were found. Additional articles were
obtained by citation tracking of review and original articles. The
books, reports, and fact sheets that include information about the
disease were searched through the following sources:
World Health Organization (WHO) (http://www.who.int/);
World Organization of Animal Health (OIE) (http://www.oie.int/);
Food and Agriculture Organization of United Nation (FAO)
(http://www.fao.org/); Google scholar (http://scholar.google.
com/); United States Center for Emerging Issues (http://www.
aphis.usda.gov/).
The 2007 Outbreak in Sudan
The recent RVF outbreak in Sudan came to public attention
October 18, 2007 when the Federal Ministry of Health (FMoH)
Sudan asked the WHO to assist in the investigation and control of
a suspected hemorrhagic fever outbreak (Table 1) [10]. The WHO
and FMoH teams started investigations in the White Nile state on
October 24, and on the basis of initial results, an outbreak of RVF
was declared on October 28, and more help was requested for
control measures (Table 1) [10]. In November an announcement
was made regarding RVF in animals [11]. The first index human
case was identified in early October [12], but it has been suggested
that RVF cases appeared already in the beginning of September
2007 (Table 1) [13–15].
At the end of the outbreak in January 2008, a total of 747
laboratory confirmed cases had been recorded with 230 deaths
[16]. This epidemic was the first report of RVF since 1988/89
when RVFV was implicated in febrile illness outbreaks in Sudan
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Gezira, and Sennar state near to the White Nile and the Blue Nile
Rivers, the main branches of the Nile River in Sudan (Figure 1)
[19]. Outbreaks of RVF were described during 1973, 1976, and
1981 [20–23], and serological surveys in several parts of Sudan
have detected antibodies both in livestock [24,25] and humans
[17,18,23,26]. RVF cases were also reported in 2007 from the
states of Kassala, Khartoum, and River Nile, although the cases in
Khartoum may have been acquired in other affected areas [9].
Furthermore, in New Halfa at Kassala, the heart of the second big
irrigated agricultural scheme in the country, high RVFV
immunoglobin G (IgG) antibody prevalence (82%) was found in
patients with fever of unknown origin in 2007 [27]. Unfortunately
no immunoglobin M (IgM) analysis was performed.
Sentinel animals had been surveyed during 2005–2006 in Kosti
with no evidence of RVF [11] in the same area where RVF
appeared in 2007 and 1973 [10,20,21]. After suspicion arose
regarding the human outbreak, the joint investigation team started
to collect new animal samples, and RVF was demonstrated in
livestock followed by the declaration of an epizootic (Table 1).
Unfortunately, there are no records or reports of the number of
affected animals or deaths during the RVF outbreak [28]. Ideally,
animals should serve as sentinels to prevent loss of human life, but
the situation here was reversed, similar to the RVF outbreak in
Kenya 2006–2007 [29]. Most probably, requisite levels of livestock
infection are necessary before virus causes detectable severe
disease in humans [29].
Human Disease
Disabilities associated with the disease and the cost of treatment
is a burden for the health system during an epidemic. In a recent
publication the number of human cases estimated in the Sudan
outbreak was 75,000 [12] compared to the 747 recorded cases
from hospitals [16]. The underestimation of RVF is probably due
to poor health infrastructure in rural areas. The high case fatality
rate recorded (30.8%) in the epidemic was similar to some
previous outbreaks in other countries [30,31], but one can suspect
that the high mortality was likely influenced by the low proportion
of patients infected with RVF that seek medical care and were
diagnosed. Although RVFV was isolated during the outbreak,
there are no reports on viral genome comparison to other strains.
Such sequence information could elucidate virus geographical
transmission patterns and potentially important genetic differences
that may exist. Interestingly, lineages isolated in Kenya differed in
expansion and prevalence, suggesting important differences in
reproductive fitness [32].
Clinical symptoms reported during the Sudan outbreak were
fever, hemorrhagic symptoms, hepato-renal failure, and ocular
complications [13–15]. Interestingly, 60% of RVF patients
admitted to the Medani Hospital in El Gezira had renal
impairment with high mortality (31%) [15], consistent with other
studies from Sudan [14] and Saudi Arabia [33]. A recent report
suggests an identifiable clinical syndrome of severe RVF,
characterized by fever, large-joint arthralgia, and gastrointestinal
complaints, later followed by jaundice, right upper-quadrant pain,
and delirium, often coinciding with hemorrhagic manifestations
[34]. The studies from Sudan suggest that renal failure could also
be a possible identifying syndrome, an interesting feature similar to
other Bunyaviridae such as the Hantaviruses that cause hemorrhagic
fever with renal syndrome [35].
Risk Factors for Severe RVFV Infection
Mosquitoes play a crucial role in transmission to animals and
humans, but the most important risk factor for severe infection is
contact with RVFV-infected animals such as consuming or
handling products from sick animals, touching an aborted animal
foetus, or being a herdsperson [36]. During the Sudan outbreak,
animal contact seemed to be the most dominant risk factor
followed by animal products and mosquito bites [15], similar to
studies conducted during previous RVF outbreaks in other
countries [37–40]. The findings concur with another study from
Sudan stating that most of the animals such as sheep, cattle, goat,
and camels stay very close to their owners’ houses at night [13].
Many patients did not know how they contracted the disease, and
one has to bear in mind that mosquito abundance was high in the
area [15].
During the outbreak, a serious case of vertical transmission from
mother to the baby was documented [41], similar to a previously
reported case in Saudi Arabia in 2000 [42]. Many maternal deaths
were observed in Central Sudan during the RVF outbreak [41],
consistent with the claims recently made about the burden of
emerging zoonotic infectious disease among women in general,
and pregnant women in particular [43].
There was no evidence for horizontal transmission between
humans in Sudan or elsewhere. However, health workers may
contract many other viral diseases while dealing with patient
excretions and therefore it is recommendable that the medical
staffs take precautions with such cases. Laboratory personnel could
also be at risk when handling samples [44].
Sociodemographic Determinants
The majority of the RVF patients in Sudan lived in rural areas,
but the reported number of shepherds infected was rather low,
probably explained by less availability to health care leading to
underestimation of true affected population [15]. As in Tanzania
2007 [45], more RVF cases were found in men than women, most
probably due to participation of men in animal slaughter and
breeding [13–15,27]. Many of the cases among women were
housewives, reflecting that women generally take care of the
animals at home, prepare animal products and milk from
potentially infected animals [13]. Most of the RVF patients were
aged 15 to 29 years, younger than in Kenya [31] or Tanzania
[45]. These were people in the active years of life [13,15], resulting
in an increased negative impact on the rural economy. The disease
burden is most likely also increased when the infected person is the
head of his/her household, but an in-depth study of the disease
Table 1. Sequence of events, actions, and response related to
the RVF outbreak in Sudan 2007.
Date Event, Action, and/or Response
June 2007 Early warning alert [12]
June–August 2007 Heavy rains and flooding [46,47]
September 2007 Suspected human RVF cases [13–15]
October 8–14, 2007 First human index case [12]
October 18, 2007 FMoH Sudan asks WHO for assistance [10]
October 24, 2007 FMoH and WHO teams start investigation [10,11]
October 28, 2007 Outbreak of RVF declared [10,11]
November 10, 2007 Outbreak of RVFV in livestock declared [11]
November 19, 2007 Start of targeted vaccination [73]
January 2008 End of outbreak [74]
doi:10.1371/journal.pntd.0001229.t001
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students were also infected most probably through mosquito bites
[15], showing that the disease had spread not only to persons who
deal with infected animals [13].
Climatic and Geographical Conditions
Outbreaks of RVF are associated with heavy rainfall and
flooding, increasing the population of mosquitoes leading to
transmission of the infection, such as in the devastating outbreak in
East Africa in 2006–2007 [31]. The Sudan outbreak also followed
an unusually heavy rainfall in the country with severe flooding
[46]. The heavy rains started in June 2007 and continued into
August, causing an overflow of the main rivers. The areas where
RVF outbreaks later occurred were among the flooded parts of
Sudan and the 2007 season was one of the wettest recorded [47].
The Sudan outbreak was predicted in June 2007 using satellite
measurements of sea surface temperatures, vegetation index, and
elevated rainfall data (Table 1) [12]. Half of the human cases were
geographically correctly predicted, and the cases in other areas
were partly due to movements of viremic animals to other
ecological zones, as in the El Gezira irrigation scheme [12].
The environment in the three affected states is suitable for
agriculture with large numbers of susceptible animals serving as
virus amplifiers. The humid climatic conditions support prolifera-
tionofthemosquitoes, the main vectorof the disease.The ElGezira
state was the worst affected area and most of the patients lived close
to irrigation canal areas, linked to naturally occurring cycles
involving livestock and mosquitoes [19], similar to the Ifakarra rice
valley in Tanzania and highlands in Madagascar where large Culex
mosquito populations could function as secondary vectors [12].
Modification of the environment has been associated with
outbreaks of diseases transmitted by mosquitoes. For instance,
water impoundments like large dams have been shown to
exacerbate malaria transmission in malaria endemic parts of sub-
Saharan Africa [48], similar to Egypt in 1977 when RVF appeared
during the construction of Aswan dam on the Nile River [49].
Furthermore,an increased risk ofRVFV amplification was reported
from the Diama and Manantali Dams, implemented to regulate the
Senegal River [50]. In 2009 Sudan finished construction of a new
dam (Merowe dam) on the Nile river basin in the Northern state,
350 kilometers from the capital for the purpose of power and
agriculture (Figure 1). Twenty years earlier there was human
serological evidence of RVFV in the same area as the dam [17],
suggesting virus circulation there. Surveillance among animals and
mosquitoes aroundnewdams and floodedareas could be ofvalue as
an early warning and has to be considered.
The Role of Vectors and Possible Reservoirs
Mosquito species composition, densities, and infection varies
within a country and different mosquito species could serve as
epizootic/epidemic vectors of RVFV in diverse ecologies, creating
a complex epidemiologic pattern [51]. Flood water Aedes species
such as Aedes mcintoshi, Ae. ochraceous, Ae. vexans are considered the
main mosquito vectors responsible for the vertical transmission of
the virus [49,52–54]. Infected eggs may stay for a long time in dry
conditions until heavy rains fall and flood the grounds sufficiently
to create good habitat and enable them to hatch and mature.
Transovarially infected adult mosquitoes can then transmit RVFV
to susceptible animals nearby, maintaining the virus during
interepizootic period. High viremia in animals then leads to
infection of secondary arthropod vector species including Culex
and Anopheles species followed by spread to additional animals and
humans [51,53,55]. Other insects like sand flies and ticks play
some undetermined role.
In December 2007, adult and immature mosquitoes were
collected in the White Nile state, one of the epidemic regions in
Sudan, and Khartoum state, which supposedly only had imported
cases [9]. The most frequent mosquito species with RVFV
infection was Anopheles gambiae arabiensis in White Nile state, and
Culex pipiens complex in Khartoum state [13]. Other species such
as, Aedes aegypti, An. coustani, and Cx. poicilipes played a less
important role. Since the vector collection was performed at the
end of the outbreak the RVFV positive Anopheles and Culex
mosquitoes were most probably secondary vectors considering
previous reports [51,53,55]. Although RVF virus has been
detected in a number of Anopheles species [4,51], there is need to
carry out vector competence studies to determine their role in the
virus maintenance and transmission. In addition to threshold
susceptibility to infection, the abundance, longevity, distribution,
and feeding behavior must be considered in evaluating the
epidemiological capacity of a species [4,51]. RVFV was also
detected in larvae of Cx. pipens complex, An. gambiae arabiensis, An.
coustani, and Ae. aegypti and in male An. gambiae arabiensis mosquitoes
[13]. There is no evidence for vertical transmission of RVFV in
the Anopheles species, but immature mosquitoes have been shown to
be infected by ingesting RVFV infected material [56].
As discussed above, infected mosquitoes were found 2007 in
Khartoum [13]. Interestingly, during the 1973 epidemic a very
small outbreak focus was reported in animals in the same area
[24], suggesting that the virus was circulating around the capital.
As in many other countries the big cities are growing and
introduction of more livestock animals in the peripheral parts of
the city may increase the chance of the disease occurrence. This
might happen when the conditions are right, i.e., heavy rainfall,
high competent mosquito and livestock populations [57].
Infected mosquitoes and animals are important in maintaining
the level of virus during the interepidemic/epizootic periods. Small
recurring local outbreaks most likely appear and in a recent
retrospective study of RVF activity in Kenya, national RVF
epizooticswererecordedwithanaverageinterepizooticperiodof3–
6 years [57]. In Sudan, the 2007 outbreak took place 30 years after
thelastrecordedoutbreak.However,thepopulationincertainareas
had RVFVantibodies 20 years ago, suggesting that RVFis endemic
in parts of Sudan [17,18]. RVFV is infecting a multitude of animals
andneutralizingantibodieshavebeenfoundinAfricanwildlife,e.g.,
buffalo, black rhino, lesser kudu, impala, and waterbuck [58,59],
which seem more resistant to disease than, e.g., sheep, cattle, and
goats [55]. Donkeys, pigs, and rodents have also been discussed as
potential reservoir for RVFV in Egypt [60,61]. Since countries
differ in livestock and wildlife species, climatic conditions, and
mosquito populations, one must emphasize that the role of animals
in the RVFV transmission cycle has to be put into context to aid
better risk assessments in RVF contingency plans [57].
Impact on Economy
Transmission of zoonotic diseases has increased worldwide in
recent years because of increasingly intense livestock production in
areas of proximity to human populations. An RVF outbreak
results in human disease, but also large economic loss with an
impact beyond the immediate influence on the directly affected
agricultural producers [2,62]. Livestock infection causes abortions
and perinatal mortality (.95%) in herds (sheep, goats, cattle, and
camels) used for meat and dairy production and income
generation resulting in less food availability, and curtailed
monetary income with major impact on poorer communities that
www.plosntds.org 4 September 2011 | Volume 5 | Issue 9 | e1229do not have access to alternative sources of livelihood. Loss of
earnings from livestock trade occasioned by export bans resulted in
lack of finance for basic amenities like education, health, food, and
shelter [2,62]. Furthermore, inspection, monitoring, intervention,
response, and financial assistance to affected producers are costly.
Livestock and livestock products are Sudan’s second most
important source of foreign exchange after oil. In 2000, after the
RVF outbreak in the Arabian Peninsula, Saudi Arabia declared a
ban on animal export from East Africa and the export from Sudan
decreased significantly in 2000 and 2001 [63]. The economic
effects of the 2007 outbreak have not been investigated, but one
could suspect a huge economic impact on both the domestic and
international animal market of the country. It is noteworthy that
most of the exported animals come from the rural areas of Sudan,
thus the ban has most severe consequences on the rural
communities. Unfortunately no studies have been undertaken in
Sudan to explore that. In Kenya, the 2007 RVF outbreak had
wide-ranging impacts on the livestock sector as well as production
impacts and employment losses (particularly for casual labor) and
the estimated RVF induced losses were over US$32 million [64].
Concluding Remarks
The RVF outbreak in Sudan was connected to heavy rainfall,
flooding, and increased mosquito breeding and was first reported
in humans. The lesson from Sudan makes it clear that human
health is the result of sustainable relationships between humans,
animals, and the environment, summarized in the new concept
‘‘One Health One World’’ [65]. Monitoring of animal disease and
entomological events together with prediction models for climatic
changes within risk areas should be used as indicators of an RVF
outbreak [66]. Decision support tools have been developed [67],
but a combined effort to study models of disease prevention and
control before and during RVF outbreaks is needed.
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